ƒ⁄‹ˇˆ˙ . 2007 53 - jscm.org
Actinomyces bovis Harz 1877 30: 243 1980 Class 2 2(t) Actinomyces bowdenii Pascual et al. 1999 49: 1876 2(t) Actinomyces canis Hoyles et al. 2000
Download ƒ⁄‹ˇˆ˙ . 2007 53 - jscm.org
Information
Domain:
Source:
Link to this page:
Documents from same domain
CLSI A One Health Perspective on Susceptibility …
www.jscm.org1 CLSI –A One Health Perspective on Susceptibility Testing Dr. Jeffrey L. Watts, PhD, RM (NRCM), M (ASCP) Director, External Innovation –Anti-Infectives Zoetis, Inc
CT - jscm.org
www.jscm.orgct 6 ˘ˇ ˆ˙˝ ˘ ˛˚ ˜ ˘˚ ! "#$ %& ’( ) *˘ ˇ+,)- .ˆ’(˙/ ˇ˝ ˛ ˚˜ !" 01#234$5
Moraxella osloensis 1 - jscm.org
www.jscm.org4 dna 16s rrna ˘ ˇˆ8ua (5 -agagtttgatcmtggctcag-3 ), 1485b (5 -taccgttaccttgttacgac-3 ) ˙ ˝˛˚˜ pcr ˘ pcr
TRC TRCRapid M. TB - jscm.org
www.jscm.orgpcr n- -a- ˘(nalc) ˇ ˆ ˙84 ˝˛ 67 ˚˛˜ 8 ˚˛!"#$ % 3 ˚˛&’3 ˚˛ 2 ˚˛( )*1 ˚˝ +nalc ˇ ˆ˙,- .˘/01234 (pbs) ˝1,000 ml˛pcr ˙ 5 100 ml˛
バンコマイシン耐性腸球菌 - jscm.org
www.jscm.org10 日本臨床微生物学雑誌 Vol.24 No.3 2014. Ⓒ日本臨床微生物学会2014 [総 説] バンコマイシン耐性腸球菌 富田治芳 1）2）・野村隆浩・久留島潤・谷本弘一2） 1）群馬大学大学院医学系研究科細菌学分野 2）群馬大学大学院医学系研究科附属薬剤耐性菌実験施設 （平成26年7月31日受付）
coagulase-negative staphylococci
www.jscm.org7) 2003. 4: 153 155. 8) Kirchho#,L.V., J. N. Sheagren. 1985. Epidemi-ology and clinical significance of blood cul-tures positive for coagulase-negative staphylo-
Loop-mediated isothermal amplification（LAMP） …
www.jscm.orgLAMP法によるレジオネラ属菌の検出 6×106 CFU/mlおよび約6×108 CFU/mlに希釈し た。これらは95℃で5分間の熱処理後，氷冷して， 12,000 rpm，4℃，10分間の遠心分離を行 …
Fusobacterium necrophorum - jscm.org
www.jscm.orgACase of Retropharyngeal Lymph Node Abscess Which Fusobacterium necrophorum Was Isolated from Blood Culture Keiko Kaiho,1) Naruhiko Ishiwada,1) Haruka Hishiki,1) Masaharu Watanabe,2) Yoichi Kohno1)
広域β-ラクタム薬耐性に関与するβ-ラクタマーゼの …
www.jscm.org荒川宜親 14 日本臨床微生物学雑誌 Vol.13 No.3 2003. 152 までには至っていなかった。しかし，1990年には， プラスミド依存性にCAZに耐性を獲得したKlebsiella
短報 臨床分離 Chryseobacterium indologenes IND …
www.jscm.org短報 臨床分離Chryseobacterium indologenes が保有する IND-Type b-Lactamase 遺伝子の解析 永田美香1) 松本竹久2) 松原未樹2) 春日恵理子1, 2) 小穴こず枝1, 3) 川上由行1, 3)
Related documents
RISK PROFILE: MYCOBACTERIUM BOVIS IN MILK
www.foodsafety.govt.nzRISK PROFILE: MYCOBACTERIUM BOVIS IN MILK . Prepared as part of a New Zealand Food Safety Authority . contract for scientific services . by . Dr Rob Lake . Susan Gilbert
Management of Bacillus Calmette-Guérin Lymphadenitis
www.hkjpaed.orgHK J Paediatr (new series) 2011;16:85-94 Management of Bacillus Calmette-Guérin Lymphadenitis WM CHAN, YW KWAN, CW LEUNG Abstract Bacillus Calmette-Guérin (BCG) related regional lymphadenitis is not an uncommon complication following BCG vaccination. We present a case series of 11 infants with suppurative BCG lymphadenitis
Sinónimos Viabilidad, propagación y Tipo Reservorio ...
www.insht.es2. D D. DATABiO. Mycobacterium tuberculosis. D - B-M.t-12. se y permanecer suspendidas en el aire va-rias horas, pudiendo pasar de unos locales a otros a través de las corrientes de aire o
7.2--7.6 877321 21300AMY00444000 2001 11 1999 7 …
www.jjasp.jpStaphylococcus aureus, Salmonella choleraesuiss, Pseudomonas aeruginosa Mycobacterium bovis BCG Bacillus subtilis Clostridium sporogenes Trichophyton mentagrophytes
MICOBATTERI IN PATOLOGIA COMPARATA - mednat.org
www.mednat.org11 Mycobacterium Bovis (3) Eziologia 9 9La parete di M. bovis è formata da cere di tipo D (esteri di acidi micolitici) e glicolipidi, caratteristica che gli conferisce resistenza all’essiccamento, agli
Tubercolosi bovina e bufalina - salute.gov.it
www.salute.gov.itSanità animale 1 Tubercolosi bovina e bufalina . La malattia . La tubercolosi bovina è una patologia con effetti socio-economici e di salute pubblica di
Tuberculosis and air travel - WHO
www.who.intThe revised International Health Regulations, adopted in 2005, pro-vide a legal framework for a more effective coordinated international response to emergencies caused by outbreaks of infectious diseases.
Morbidity and Mortality Weekly Report
www.cdc.govVol. 54 / RR-15 Recommendations and Reports 1. Guidelines for the Investigation of Contacts of Persons with Infectious Tuberculosis. Recommendations from the National Tuberculosis